Ison, Gwynn <br/><br/>
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2016 
 - 4545-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-16-0638  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--chemistry<br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Capecitabine--administration & dosage<br/>Clinical Trials as Topic<br/>Drug Approval<br/>Drug Evaluation, Preclinical<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Neoplasms--diagnosis<br/>Prescription Drug Overuse<br/>Research Design<br/>Treatment Outcome<br/>United States<br/>United States Food and Drug Administration<br/>Uridine--analogs & derivatives